In Vitro Fertilization Market by Product, Type of Cycles & End Users - Global Forecast to 2022

Wednesday, October 11, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Oct. 11, 2017 /PRNewswire/ -- "In Vitro Fertilization market is projected to grow at a CAGR of 10.9%" The

global in vitro fertilization market is expected to grow at a CAGR of 10.9% to reach to USD 847.8 million by 2022. Factors propelling market growth include growth in the median age of first-time motherhood, declining fertility
rates, rising male infertility, rise in consumption of alcohol and cigarettes, and growing public awareness about infertility and the available treatment options. However, the high cost and low success rate of the IVF treatment and restrictive regulation and ethical concerns are expected to restrict the growth of In vitro fertilization market to a certain extent. Download the full report:"Reagents to grow at the highest CAGR during the forecast period" By product, the in vitro fertilization market is segmented into reagents and equipment. Reagents are estimated to account for the largest share in the global in vitro fertilization market in 2017. This large share can be attributed to the fact that increasing number of IVF procedures would lead to increase in the usage of reagents. "Asia Pacific to dominate the IVF market" The APAC region is expected to hold the largest share of the global in vitro fertilization market in 2017. The region is also expected to grow at the highest growth rate during the forecast period. The large share and high growth rate of the APAC region can be attributed growth in the median age of first-time motherhood, rising infertility rates, growing prevalence of PCOS, increasing incidence of obesity, the rise in fertility tourism, and government initiatives. Break of primary participants was as mentioned below: • By Company Type – Tier 1: 37%, Tier 2: 47%, and Tier 3: 16% • By Designation – C-level: 46%, Director Level: 36%, Others: 18% • By Region – North America: 38%, Europe: 22%, Asia-Pacific: 31%, RoW: 9% CooperSurgical (US), Vitrolife (Sweden), Cook Medical (US), Irvine Scientific (US), and Thermo Fisher Scientific (US) are the key players in the in vitro fertilization market. Research Coverage: The report analyzes the in vitro fertilization market and aims at estimating the market size and the future growth potential of this market based on various segments such as type of cycle, product, end user, and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies. Reasons to Buy the Report The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned strategies. This report provides insights on the following pointers: • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global in vitro fertilization market • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global in vitro fertilization market • Market Development: Comprehensive information about the lucrative emerging markets by type of cycle, product, end user and region • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global in vitro fertilization market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global marketDownload the full report: About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers  For more information: Sarah Smith Research Advisor at Email: [email protected]  Tel: +44 208 816 85 48 Website:

View original content:

SOURCE ReportBuyer

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store